We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 3

1.
Fig 2.

Fig 2. From: Identification and Validation of a Gene Expression Signature That Predicts Outcome in Adult Men With Germ Cell Tumors.

Kaplan-Meier survival curves of patients from validation set dichotomized on the basis of median score. Gold line indicates scores less than the median; blue line indicates scores greater than the median.

James E. Korkola, et al. J Clin Oncol. 2009 November 1;27(31):5240-5247.
2.
Fig A1.

Fig A1. From: Identification and Validation of a Gene Expression Signature That Predicts Outcome in Adult Men With Germ Cell Tumors.

Reverse transcriptase polymerase chain reaction validation of outcome associated genes identified by expression profiling. IgJ and SYNPO2 represent genes more highly expressed in patients with good outcome, whereas ZIC1, SOX11, and COL2A1 represent genes more highly expressed in patients with poor outcome. NED, no evidence of disease; DOD, died as a result of disease.

James E. Korkola, et al. J Clin Oncol. 2009 November 1;27(31):5240-5247.
3.
Fig 1.

Fig 1. From: Identification and Validation of a Gene Expression Signature That Predicts Outcome in Adult Men With Germ Cell Tumors.

(A) Kaplan-Meier survival curves of patients from validation set (A) who were predicted to have good (gold) or poor (blue) outcome on the basis of genes identified by prediction analysis for microarrays (PAM) to be associated with 5-year overall survival; (B) who had good (gold), intermediate (blue), and poor (gray) International Germ Cell Cancer Collaborative Group (IGCCCG) risk assessment; and (C) who had intermediate and poor IGCCCG risk assessment and good (gold) and poor (blue) PAM prediction.

James E. Korkola, et al. J Clin Oncol. 2009 November 1;27(31):5240-5247.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk